For the Inventor, By the Inventor

Enter assignee name

Richmond, VA, United States of America

A. H. Robins Company, Incorporated

Calculating rank

USPTO Granted Patents = 218

Trademarks = 24

Forward Citations = 2,280

Loading Chart...

Loading Chart...

92 inventors (with patents filed for the assignee):

Albert D Cale, Jr (46 out of 46 patents)

David A Walsh (29 out of 29 patents)

William J Welstead, Jr (29 out of 29 patents)

4. Young S Lo (23 out of 29 patents)

5. Chandler R Taylor, Jr (21 out of 21 patents)

6. Harry R Munson, Jr (18 out of 21 patents)

7. James R Shanklin, Jr (17 out of 19 patents)

8. Harold F Stauffer, Jr (9 out of 9 patents)

9. Dwight A Shamblee (8 out of 8 patents)

10. Gunnar E Jagdmann, Jr (8 out of 11 patents)

11. Ying-Ho Chen (8 out of 8 patents)

12. Carl D Lunsford (8 out of 8 patents)

13. Charles A Leonard (8 out of 8 patents)

14. Bruce E Tomczuk (7 out of 7 patents)

15. Reevis S Alphin (7 out of 7 patents)

Core Competencies:

Anxiolytics

Carboxylic Acids

Antiarrhythmic Agents

Amino Compounds

Veterinary Drugs

Therapeutic Treatments

Sulfamates

Heterocyclic Compounds

Benzamides

Carbamates

Azabicyclic Compounds

Imidazoheterocyclic Compounds

218 patents: Sort by Forward Citations

1. 5273993 - Compounds having one or more aminosulfonyloxy radicals useful as (1993-12-28),

2. 5273972 - [(2-diakylaminomethyl)-3-quinuclidinyl]-benzamides and benzoates (1993-12-28),

3. 5244907 - Carbocyclic carboxylic acid amides and esters of azabicyclic compounds (1993-09-14),

4. 5236931 - 2-substituted benzamide and benzoate derivatives of 3-aminoquinuclidine (1993-08-17),

5. 5206246 - Anxiolytic-R-n(1-azabicyclo[2.2.2]oct-3-yl) benzamides and thiobenzamides (1993-04-27),

6. 5198449 - N-substituted alpha-arylazacycloalkylmethanamines and their use as (1993-03-30),

7. 5194446 - Compounds having one or more aminosulfaonyloxy radicals useful as (1993-03-16),

8. 5192785 - Sulfamates as antiglaucoma agents (1993-03-09),

9. 5190953 - Heterocyclic carboxylic acid amides and esters of azabicyclic compounds (1993-03-02),

10. 5183903 - Urea fusion process for the synthesis of (1993-02-02),

11. 5183902 - Method of treating muscular tension, muscle spasticity and anxiety with (1993-02-02),

12. 5171753 - Derivatives of 2-amino-1-phenylethanol having antiulcer activity (1992-12-15),

13. 5162322 - Method of treating anxiety with 5-[(4-aryl or (1992-11-10),

14. 5151418 - Method of treating muscular tension, muscle spasticity and anxiety with (1992-09-29),

15. 5140026 - N-aminoalkyl-S-aryl-S-alkyl (or substituted alkyl) sulfoximines as (1992-08-18),

Company Overview

A. H. Robins Company, Incorporated, based in Richmond, VA, specializes in the development and manufacturing of pharmaceutical compounds. The company focuses on a diverse range of therapeutic areas, including anxiolytics, antiarrhythmic agents, and veterinary drugs. With expertise in carboxylic acids, amino compounds, and heterocyclic compounds, A. H. Robins is dedicated to advancing healthcare solutions through innovative drug formulations and treatments, addressing both human and veterinary medical needs.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

218 Patents

#9 in Richmond, VA

#40 in Virginia

#1,928 in US

#3,929 in the World

Richmond, VA, United States of America

A. H. Robins Company, Incorporated

Forward Citations = 2,280

92 inventors:

Albert D Cale, Jr (46 out of 46 patents)

David A Walsh (29 out of 29 patents)

William J Welstead, Jr (29 out of 29 patents)

4. Young S Lo (23 out of 29 patents)

5. Chandler R Taylor, Jr (21 out of 21 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: A. H. Robins Company, Incorporated. Retrieved from https://idiyas.com/company/a-h-robins-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…